Rhenman & Partners Asset Management AB
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1599882
Stockholm, V7
Position in ESPR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
985,000
-7.6% QoQ
Ownership
0.383%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $24,174,742 across 2 Drug Manufacturers - Specialty & Generic names.
All Filings in ESPR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 985,000 | Shares | Sole | 2026-05-14 | |
| 2025-03-31 | — | 1,066,495 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | — | 1,915,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | — | 1,975,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | — | 1,975,000 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | — | 900,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | — | 900,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | — | 900,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | — | 900,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | — | 981,582 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | — | 1,000,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | — | 622,267 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | — | 572,267 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | — | 592,225 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | — | 592,225 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | — | 455,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | — | 425,000 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | — | 592,798 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||